Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 163 SEK 0.74% Market Closed
Market Cap: 12.9B SEK
Have any thoughts about
Biotage AB?
Write Note

Wall Street
Price Targets

BIOT Price Targets Summary
Biotage AB

Wall Street analysts forecast BIOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOT is 218.03 SEK with a low forecast of 161.6 SEK and a high forecast of 288.75 SEK.

Lowest
Price Target
161.6 SEK
1% Downside
Average
Price Target
218.03 SEK
34% Upside
Highest
Price Target
288.75 SEK
77% Upside
Biotage AB Competitors:
Price Targets
SKAN
SKAN Group AG
19% Upside
4880
CellSource Co Ltd
39% Upside
ABSI
Absci Corp
112% Upside
CHEMM
Chemometec A/S
18% Upside
AVTR
Avantor Inc
25% Upside
LONN
Lonza Group AG
15% Upside
TKNO
Alpha Teknova Inc
12% Downside
TMO
Thermo Fisher Scientific Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 15%.

15%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 28%.

21%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotage AB

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 32%.

16%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOT's stock price target?
Price Target
218.03 SEK

According to Wall Street analysts, the average 1-year price target for BIOT is 218.03 SEK with a low forecast of 161.6 SEK and a high forecast of 288.75 SEK.

What is Biotage AB's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Biotage AB's revenue is 15%. The projected CAGR for the next 3 years is 15%.

What is Biotage AB's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Biotage AB's operating income is 21%. The projected CAGR for the next 3 years is 28%.

What is Biotage AB's Net Income forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Biotage AB's net income is 16%. The projected CAGR for the next 3 years is 32%.

Back to Top